Proteomic profiling of lung diffusion impairment in the recovery stage of SARS-CoV-2-induced ARDS

Clin Transl Med. 2022 May;12(5):e838. doi: 10.1002/ctm2.838.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Lung
  • Proteomics
  • Respiratory Distress Syndrome*
  • SARS-CoV-2